Literature DB >> 21337366

Directing dopaminergic fiber growth along a preformed molecular pathway from embryonic ventral mesencephalon transplants in the rat brain.

Y Jin1, C Zhang, K S Ziemba, G A Goldstein, P G Sullivan, G M Smith.   

Abstract

To identify guidance molecules to promote long-distance growth of dopaminergic axons from transplanted embryonic ventral mesencephalon (VM) tissue, three pathways were created by expressing green fluorescent protein (GFP), glial cell line-derived neurotrophic factor (GDNF), or a combination of GDNF/GDNF receptor α1 (GFRα1) along the corpus callosum. To generate the guidance pathway, adenovirus encoding these transcripts was injected at four positions along the corpus callosum. In all groups, GDNF adenovirus was also injected on the right side 2.5 mm from the midline at the desired transplant site. Four days later, a piece of VM tissue from embryonic day 14 rats was injected at the transplant site. All rats also received daily subcutaneous injections of N-acetyl-L-cysteinamide (NACA; 100 μg per rat) as well as chondroitinase ABC at transplant site (10 U/ml, 2 μl). Two weeks after transplantation, the rats were perfused and the brains dissected out. Coronal sections were cut and immunostained with antibody to tyrosine hydroxylase (TH) to identify and count dopaminergic fibers in the corpus callosum. In GFP-expressing pathways, TH(+) fibers grew out of the transplants for a short distance in the corpus callosum. Very few TH(+) fibers grew across the midline. However, pathways expressing GDNF supported more TH(+) fiber growth across the midline into the contralateral hemisphere. Significantly greater numbers of TH(+) fibers grew across the midline in animals expressing a combination of GDNF and GFRα1 in the corpus callosum. These data suggest that expression of GDNF or a combination of GDNF and GFRα1 can support the long-distance dopaminergic fiber growth from a VM transplant, with the combination having a superior effect.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21337366      PMCID: PMC4038386          DOI: 10.1002/jnr.22575

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  39 in total

Review 1.  Transplantation in the rat model of Parkinson's disease: ectopic versus homotopic graft placement.

Authors:  C Winkler; D Kirik; A Björklund; S B Dunnett
Journal:  Prog Brain Res       Date:  2000       Impact factor: 2.453

2.  Target-derived GFRalpha1 as an attractive guidance signal for developing sensory and sympathetic axons via activation of Cdk5.

Authors:  Fernanda Ledda; Gustavo Paratcha; Carlos F Ibáñez
Journal:  Neuron       Date:  2002-10-24       Impact factor: 17.173

3.  Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord.

Authors:  J W McDonald; X Z Liu; Y Qu; S Liu; S K Mickey; D Turetsky; D I Gottlieb; D W Choi
Journal:  Nat Med       Date:  1999-12       Impact factor: 53.440

4.  Transplants of fibroblasts genetically modified to express BDNF promote axonal regeneration from supraspinal neurons following chronic spinal cord injury.

Authors:  Ying Jin; Itzhak Fischer; Alan Tessler; John D Houle
Journal:  Exp Neurol       Date:  2002-09       Impact factor: 5.330

5.  Chondroitinase ABC promotes functional recovery after spinal cord injury.

Authors:  Elizabeth J Bradbury; Lawrence D F Moon; Reena J Popat; Von R King; Gavin S Bennett; Preena N Patel; James W Fawcett; Stephen B McMahon
Journal:  Nature       Date:  2002-04-11       Impact factor: 49.962

6.  Transplantation treatment of spinal cord injury patients.

Authors:  Samuil S Rabinovich; Victor I Seledtsov; Olga V Poveschenko; Vladimir V Senuykov; Vadim Y Taraban; Vladimir I Yarochno; Nicolay G Kolosov; Sergey A Savchenko; Vladimir A Kozlov
Journal:  Biomed Pharmacother       Date:  2003-11       Impact factor: 6.529

7.  The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury.

Authors:  Leonard L Jones; Richard U Margolis; Mark H Tuszynski
Journal:  Exp Neurol       Date:  2003-08       Impact factor: 5.330

8.  Glial cell line-derived neurotrophic factor-supplemented hibernation of fetal ventral mesencephalic neurons for transplantation in Parkinson disease: long-term storage.

Authors:  Adam O Hebb; Kari Hebb; Arun C Ramachandran; Ivar Mendez
Journal:  J Neurosurg       Date:  2003-05       Impact factor: 5.115

9.  Neuroprotective effect of N-acetylcysteine and hypothermia on the spinal cord ischemia-reperfusion injury.

Authors:  Omer Cakir; Kemalettin Erdem; Ahmet Oruc; Nihal Kilinc; Nesimi Eren
Journal:  Cardiovasc Surg       Date:  2003-10

10.  Inhibitory effect on cerebral inflammatory response following traumatic brain injury in rats: a potential neuroprotective mechanism of N-acetylcysteine.

Authors:  Gang Chen; Jixin Shi; Zhigang Hu; Chunhua Hang
Journal:  Mediators Inflamm       Date:  2008       Impact factor: 4.711

View more
  5 in total

1.  Differential effects of distinct central nervous system regions on cell migration and axonal extension of neural precursor transplants.

Authors:  Ying Jin; Karna Sura; Itzhak Fischer
Journal:  J Neurosci Res       Date:  2012-06-27       Impact factor: 4.164

2.  Long distance directional growth of dopaminergic axons along pathways of netrin-1 and GDNF.

Authors:  C Zhang; Y Jin; K S Ziemba; A M Fletcher; B Ghosh; E Truit; D M Yurek; G M Smith
Journal:  Exp Neurol       Date:  2013-10-04       Impact factor: 5.330

3.  Modality-specific axonal regeneration: toward selective regenerative neural interfaces.

Authors:  Parisa Lotfi; Kshitija Garde; Amit K Chouhan; Ebrahim Bengali; Mario I Romero-Ortega
Journal:  Front Neuroeng       Date:  2011-10-12

4.  Partial Reconstruction of the Nigrostriatal Circuit along a Preformed Molecular Guidance Pathway.

Authors:  Biswarup Ghosh; Chen Zhang; Kristine S Ziemba; Anita M Fletcher; David M Yurek; George M Smith
Journal:  Mol Ther Methods Clin Dev       Date:  2019-07-11       Impact factor: 6.698

5.  Chondroitinase ABC reduces dopaminergic nigral cell death and striatal terminal loss in a 6-hydroxydopamine partial lesion mouse model of Parkinson's disease.

Authors:  Edward J R Fletcher; Lawrence D F Moon; Susan Duty
Journal:  BMC Neurosci       Date:  2019-12-20       Impact factor: 3.288

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.